Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Bootz

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|July 20, 2016
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinibAnne von Mässenhausen, Christine Sanders, Johannes Brägelmann, et al.
Anticancer Research|December 7, 2016
Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma PatientsSebastian Meller, Anne VAN Ellen, Heidrun Gevensleben, et al.
Plos One|April 2, 2013
Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancerAndreas Schröck, Friederike Göke, Patrick Wagner, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Ebiomedicine|February 7, 2020
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanomaAnne Fröhlich, Sophia Loick, Emma Grace Bawden, et al.
Carcinogenesis|April 19, 2014
Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinomaAndreas Schröck, Maike Bode, Friederike Johanna Maria Göke, et al.
Ebiomedicine|October 20, 2019
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signatureVerena Sailer, Ulrike Sailer, Emma Grace Bawden, et al.
Clinical Chemistry|July 21, 2023
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma PatientsDimo Dietrich, Simone Weider, Luka de Vos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2013
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neckFriederike Göke, Maike Bode, Alina Franzen, et al.
Clinical Chemistry|May 19, 2017
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort StudyAndreas Schröck, Annette Leisse, Luka de Vos, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|July 20, 2016
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinibAnne von Mässenhausen, Christine Sanders, Johannes Brägelmann, et al.
Anticancer Research|December 7, 2016
Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma PatientsSebastian Meller, Anne VAN Ellen, Heidrun Gevensleben, et al.
Plos One|April 2, 2013
Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancerAndreas Schröck, Friederike Göke, Patrick Wagner, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Ebiomedicine|February 7, 2020
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanomaAnne Fröhlich, Sophia Loick, Emma Grace Bawden, et al.
Carcinogenesis|April 19, 2014
Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinomaAndreas Schröck, Maike Bode, Friederike Johanna Maria Göke, et al.
Ebiomedicine|October 20, 2019
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signatureVerena Sailer, Ulrike Sailer, Emma Grace Bawden, et al.
Clinical Chemistry|July 21, 2023
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma PatientsDimo Dietrich, Simone Weider, Luka de Vos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2013
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neckFriederike Göke, Maike Bode, Alina Franzen, et al.
Clinical Chemistry|May 19, 2017
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort StudyAndreas Schröck, Annette Leisse, Luka de Vos, et al.
Pageof 10